The effects of an acetylcholine analogue, carbachol (CCh), and a purified irreversible nicotinic antagonist, -bungarotoxin (BTX), on the frequency of the miniature endplate potentials (mEPPs) at the neuromuscular junction of the frog were tested at 20 and 10 C. CCh (5 10-6 m) reduced the frequency of mEPPs to about 60 %; this reduction was not affected by 1 10-7 g ml-1 BTX. BTX also reversibly decreased the mEPP frequency by 40 %, but not in the presence of CCh or in Ringer solution with 0 or 8 mM Ca2+. The present data show that BTX, which inhibits a class of nicotinic ACh receptors, does not block the decrease of mEPP frequency evoked by CCh and can itself suppress the frequency of spontaneous quantal release.

The effects of an acetylcholine analogue, carbachol (CCh), and a purified irreversible nicotinic antagonist, -bungarotoxin (BTX), on the frequency of the miniature endplate potentials (mEPPs) at the neuromuscular junction of the frog were tested at 20 and 10 C. CCh (5 10-6 m) reduced the frequency of mEPPs to about 60 %; this reduction was not affected by 1 10-7 g ml-1 BTX. BTX also reversibly decreased the mEPP frequency by 40 %, but not in the presence of CCh or in Ringer solution with 0 or 8 mM Ca2+. The present data show that BTX, which inhibits a class of nicotinic ACh receptors, does not block the decrease of mEPP frequency evoked by CCh and can itself suppress the frequency of spontaneous quantal release.